Search results
Lilly’s Phase II results in Alzheimer’s disease have most experts saying donanemab is done
Clinical Trials Arena via Yahoo Finance· 1 hour agoEli Lilly’s donanemab for early symptomatic Alzheimer’s disease (AD) has most experts dubious of the...
Amneal’s IPX-203 shows promising results for motor fluctuations in Parkinson’s disease
Clinical Trials Arena via Yahoo Finance· 1 hour agoThe trial evaluated 506 PD patients with motor fluctuations. IPX-203 met the study’s primary...
SAGE's Huntington's Disease Study Meets Primary Endpoint
Zacks via Yahoo Finance· 5 days agoThe phase II SURVEYOR study evaluating SAGE's dalzanemdor as a potential treatment for patients with...
UK’s HEAL grant didn’t meet overdose death reduction goal, but still counts successes
Lexington Herald-Leader McClatchy via AOL· 16 hours agoNIH’s National Institute for Drug Abuse and the University of Kentucky said Sunday the four-year...
ALS pipeline suffers a major hit as Biogen’s Tofersen fails phase iii trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoBiogen's Tofersen did not meet its efficacy results in the Phase III VALOR study for ALS, which...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 5 days agoModerna has announced positive Phase III data for its Covid-19/influenza combination vaccine,...
'Dramatic' Phase 2 Results for Survodutide in MASH, Fibrosis
Medscape· 5 days agoSurvodutide, a dual agonist that targets glucagon and glucagon-like peptide 1 receptors, led to a ...
I just experienced a new AI mind reading tool — here’s what happened
Tom's Guide via Yahoo News· 4 days agoTheir success rate for MindGPT is 42% — a statistically significant figure that shows it is...
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 4 days agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast...
Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...
FOX 23 News Albany· 2 days agoJohnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...